Stifel Maintains Buy on Boston Scientific, Raises Price Target to $60
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise maintains a 'Buy' rating on Boston Scientific (NYSE:BSX) and raises the price target from $58 to $60.
September 21, 2023 | 4:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst maintains a 'Buy' rating on Boston Scientific and raises the price target to $60.
The raised price target by Stifel indicates a positive outlook for Boston Scientific. This could potentially lead to an increase in the stock price in the short term as it signals confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100